166 related articles for article (PubMed ID: 12678723)
1. Signal transduction inhibitors as radiosensitizers.
Tenzer A; Zingg D; Riesterer O; Vuong V; Bodis S; Pruschy M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):727-42. PubMed ID: 12678723
[TBL] [Abstract][Full Text] [Related]
2. Current concepts for the combined treatment modality of ionizing radiation with anticancer agents.
Oehler C; Dickinson DJ; Broggini-Tenzer A; Hofstetter B; Hollenstein A; Riesterer O; Vuong V; Pruschy M
Curr Pharm Des; 2007; 13(5):519-35. PubMed ID: 17348847
[TBL] [Abstract][Full Text] [Related]
3. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.
Ding M; Zhang E; He R; Wang X
Cancer Sci; 2013 Nov; 104(11):1401-10. PubMed ID: 23930697
[TBL] [Abstract][Full Text] [Related]
4. Combining anti-tumor alkyl-phospholipid analogs and radiotherapy: rationale and clinical outlook.
Verheij M; Moolenaar WH; Blitterswijk WJ
Anticancer Agents Med Chem; 2014 May; 14(4):618-28. PubMed ID: 24628238
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
7. ATM as a target for novel radiosensitizers.
Sarkaria JN; Eshleman JS
Semin Radiat Oncol; 2001 Oct; 11(4):316-27. PubMed ID: 11677656
[TBL] [Abstract][Full Text] [Related]
8. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase I-targeting drugs as radiation sensitizers.
Chen AY; Choy H; Rothenberg ML
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):39-46. PubMed ID: 10550825
[TBL] [Abstract][Full Text] [Related]
10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
12. Targeting the AKT pathway: Repositioning HIV protease inhibitors as radiosensitizers.
Goda JS; Pachpor T; Basu T; Chopra S; Gota V
Indian J Med Res; 2016 Feb; 143(2):145-59. PubMed ID: 27121513
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside.
Sriramulu S; Thoidingjam S; Brown SL; Siddiqui F; Movsas B; Nyati S
Biomed Pharmacother; 2023 Feb; 158():114126. PubMed ID: 36521246
[TBL] [Abstract][Full Text] [Related]
14. Targeted cancer therapies based on the inhibition of DNA strand break repair.
O'Connor MJ; Martin NM; Smith GC
Oncogene; 2007 Dec; 26(56):7816-24. PubMed ID: 18066095
[TBL] [Abstract][Full Text] [Related]
15. NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P; Coleman CN; Dicker AP
J Natl Cancer Inst; 2013 Jan; 105(1):11-24. PubMed ID: 23231975
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
Weinmann M; Welz S; Bamberg M
Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
[TBL] [Abstract][Full Text] [Related]
17. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization.
Kuger S; Flentje M; Djuzenova CS
Radiat Oncol; 2015 Oct; 10():214. PubMed ID: 26498922
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitors of the heat shock protein 90 activity: a novel class of tumor radiosensitizers].
Kabakov AE; Kudriavtsev VA; Makarova IuM
Radiats Biol Radioecol; 2010; 50(5):528-35. PubMed ID: 21261003
[TBL] [Abstract][Full Text] [Related]
20. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
Luo Y; Leverson JD
Expert Rev Anticancer Ther; 2005 Apr; 5(2):333-42. PubMed ID: 15877529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
